Therapy-related acute myelogenous leukemia in... [Ann Intern Med. 2011] - PubMed

loading

Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea. [Ann Intern Med. 2000]
Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea.
Wilson S. Ann Intern Med. 2000 Dec 5; 133(11):925-6.
Hydroxyurea for sickle cell anemia. [N Engl J Med. 2008]
Hydroxyurea for sickle cell anemia.
Bachmeyer C, Aractingi S, Lionnet F. N Engl J Med. 2008 Jul 3; 359(1):98; author reply 98-9.
Review Hydroxyurea for the treatment of sickle cell anemia. [N Engl J Med. 2008]
Review Hydroxyurea for the treatment of sickle cell anemia.
Platt OS. N Engl J Med. 2008 Mar 27; 358(13):1362-9.
Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results. [BMJ. 1998]
Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.
Olujohungbe A, Cinkotai KI, Yardumian A. BMJ. 1998 Jun 6; 316(7146):1689.
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. [Ann Intern Med. 2008]
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, et al. Ann Intern Med. 2008 Jun 17; 148(12):932-8. Epub 2008 May 5.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with...
Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia.
Ann Intern Med. 2011 Nov 15 ;155(10):722-4.

PubMed
Effect of 12 months of whole-body vibration therapy on bone density and structur...
Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.
Ann Intern Med. 2011 Nov 15 ;155(10):668-79, W205.

PubMed
Medical-legal partnership: impact on patients with sickle cell disease.
Medical-legal partnership: impact on patients with sickle cell disease.
Pediatrics. 2011 Dec ;128(6):e1482-8. Epub 2011 Nov 14 .

PubMed
Chloroquine and hydroxychloroquine toxicity.
Chloroquine and hydroxychloroquine toxicity.
Arch Ophthalmol. 2011 Nov ;129(11):1506-7.

PubMed
Distinguishing benign from malignant masses at breast US: combined US elastograp...
Distinguishing benign from malignant masses at breast US: combined US elastography and color doppler US--influence on radiologist accuracy.
Radiology. 2012 Jan ;262(1):80-90. Epub 2011 Nov 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed